GenSight Biologics S.A.
GSGTF
$0.19
-$0.05-20.79%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -25.62% | -15.49% | 43.38% | 42.24% | 51.66% |
| Total Depreciation and Amortization | -68.35% | -70.90% | -68.36% | -67.73% | -13.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.57% | 110.63% | -81.42% | -81.05% | 76.07% |
| Change in Net Operating Assets | 669.90% | 623.93% | -18.81% | -17.18% | -273.21% |
| Cash from Operations | 64.70% | 67.55% | 34.51% | 33.19% | 55.19% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -530.00% | -492.96% | -92.39% | -92.48% | -91.60% |
| Cash from Investing | -563.08% | -529.23% | -91.03% | -91.15% | -92.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 13.02% | 13.02% | -754.98% | -754.98% | 74.27% |
| Issuance of Common Stock | -93.29% | -93.29% | -14.52% | -14.52% | 5,040.00% |
| Repurchase of Common Stock | -- | -- | 94.95% | 94.95% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -103.33% | -103.33% | 892.05% | 892.05% | 904.55% |
| Cash from Financing | -97.30% | -97.52% | -85.26% | -84.96% | 87.26% |
| Foreign Exchange rate Adjustments | 104.55% | 90.91% | -573.95% | -584.57% | -92.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -148.14% | -144.25% | -498.30% | -506.31% | 149.56% |